1 1423 136 IMPROVEMENT IN NEUROCOGNITIVE FUNCTIONS AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS IN PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS AND YOGA. CONTEXT AND AIMS: IMPAIRMENT IN COGNITION IS WELL-KNOWN IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. THIS STUDY EXAMINED THE EFFECT OF YOGA THERAPY WITH OR WITHOUT ANTIDEPRESSANTS AND ANTIDEPRESSANTS ALONE ON CERTAIN NEUROPSYCHOLOGICAL FUNCTIONS IN PATIENTS WITH DEPRESSION. CORRELATION BETWEEN CHANGES IN NEUROPSYCHOLOGICAL TEST PERFORMANCE AND SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS WAS ALSO EXPLORED. MATERIALS AND METHODS: ANTIDEPRESSANT-NAIVE/ANTIDEPRESSANT-FREE OUTPATIENTS WITH DEPRESSION RECEIVED ANTIDEPRESSANT MEDICATION ALONE (N = 23) OR YOGA THERAPY WITH (N = 26) OR WITHOUT (N = 16) ANTIDEPRESSANTS. DEPRESSION WAS ASSESSED USING THE HAMILTON DEPRESSION RATING SCALE. NEUROPSYCHOLOGICAL TESTS INCLUDED DIGIT-SPAN FORWARD AND BACKWARD, REY AUDITORY VERBAL LEARNING TEST, AND TRAIL MAKING TESTS (TMT-A AND B). THESE TESTS WERE ADMINISTERED BEFORE AND 3 MONTHS AFTER THE TREATMENT IN PATIENTS, AND ONCE IN HEALTHY COMPARISON SUBJECTS (N = 19). STATISTICAL ANALYSIS: BASELINE DIFFERENCES WERE ANALYZED USING INDEPENDENT SAMPLE T-TEST, CHI-SQUARE, AND ONE-WAY ANOVA. PAIRED T-TEST WAS USED TO ANALYZE THE CHANGE FROM BASELINE TO FOLLOW-UP. PEARSON'S CORRELATION WAS USED TO EXPLORE THE ASSOCIATION OF CHANGE BETWEEN 2 VARIABLES. RESULTS: PATIENTS HAD IMPAIRED PERFORMANCE ON MOST NEUROPSYCHOLOGICAL TESTS. AFTER 3 MONTHS, THERE WAS SIGNIFICANT IMPROVEMENT - PATIENTS' PERFORMANCE WAS COMPARABLE TO THAT OF HEALTHY CONTROLS ON MAJORITY OF THE TESTS. SIGNIFICANT INVERSE CORRELATION WAS OBSERVED BETWEEN INCREASE IN BDNF LEVELS AND IMPROVEMENT IN TMT "A" DURATION IN YOGA-ALONE GROUP (R = -0.647; P = 0.009). CONCLUSIONS: TO CONCLUDE THAT, YOGA THERAPY, ALONE OR IN COMBINATION WITH MEDICATIONS, IS ASSOCIATED WITH IMPROVED NEUROPSYCHOLOGICAL FUNCTIONS AND NEUROPLASTIC EFFECTS IN PATIENTS WITH DEPRESSION. 2018 2 1967 63 SERUM CORTISOL AND BDNF IN PATIENTS WITH MAJOR DEPRESSION-EFFECT OF YOGA. DEPRESSION IS ASSOCIATED WITH LOW SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND ELEVATED LEVELS OF SERUM CORTISOL. YOGA PRACTICES HAVE BEEN ASSOCIATED WITH ANTIDEPRESSANT EFFECTS, INCREASE IN SERUM BDNF, AND REDUCTION IN SERUM CORTISOL. THIS STUDY EXAMINED THE ASSOCIATION BETWEEN SERUM BDNF AND CORTISOL LEVELS IN DRUG-NAIVE PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS, YOGA THERAPY, AND BOTH. FIFTY-FOUR DRUG-NAIVE CONSENTING ADULT OUTPATIENTS WITH MAJOR DEPRESSION (32 MALES) RECEIVED ANTIDEPRESSANTS ONLY (N = 16), YOGA THERAPY ONLY (N = 19), OR YOGA WITH ANTIDEPRESSANTS (N = 19). SERUM BDNF ANDCORTISOL LEVELS WERE OBTAINED BEFORE AND AFTER 3 MONTHS USING A SANDWICH ELISA METHOD. ONE-WAY ANOVA, CHI-SQUARE TEST, AND PEARSON'S CORRELATION TESTS WERE USED FOR ANALYSIS. THE GROUPS WERE COMPARABLE AT BASELINE ON MOST PARAMETERS. SIGNIFICANT IMPROVEMENT IN DEPRESSION SCORES AND SERUM BDNF LEVELS, AND REDUCTION IN SERUM CORTISOL IN THE YOGA GROUPS, HAVE BEEN DESCRIBED IN PREVIOUS REPORTS. A SIGNIFICANT NEGATIVE CORRELATION WAS OBSERVED BETWEEN CHANGE IN BDNF (PRE-POST) AND CORTISOL (PRE-POST) LEVELS IN THE YOGA-ONLY GROUP (R = -0.59, P = 0.008). IN CONCLUSION, YOGA MAY FACILITATE NEUROPLASTICITY THROUGH STRESS REDUCTION IN DEPRESSED PATIENTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE FINDINGS AND DELINEATE THE PATHWAYS FOR THESE EFFECTS. 2016 3 1761 53 POSITIVE THERAPEUTIC AND NEUROTROPIC EFFECTS OF YOGA IN DEPRESSION: A COMPARATIVE STUDY. CONTEXT: THERAPEUTIC EFFECT OF YOGA IN DEPRESSION IS RECOGNIZED. NEUROPLASTIC EFFECTS OF ANTIDEPRESSANT THERAPIES ARE INFERRED BY ELEVATIONS IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF). ROLE OF YOGA IN BOTH THESE EFFECTS HAS NOT BEEN STUDIED. MATERIALS AND METHODS: NON-SUICIDAL, CONSECUTIVE OUT-PATIENTS OF DEPRESSION WERE OFFERED YOGA EITHER ALONE OR WITH ANTIDEPRESSANTS. THE DEPRESSION SEVERITY WAS RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) BEFORE AND AT 3 MONTHS. SERUM BDNF LEVELS WERE MEASURED AT THE SAME TIME POINTS. REPEATED-MEASURES ANALYSIS OF VARIANCE WAS PERFORMED TO LOOK AT CHANGE ACROSS GROUPS WITH RESPECT TO HDRS SCORES AND BDNF LEVELS OVER 3 MONTHS OF FOLLOW-UP. RELATIONSHIP BETWEEN CHANGE IN SERUM BDNF LEVELS AND CHANGE IN HDRS SCORES WAS ASSESSED USING THE PEARSON'S CORRELATION COEFFICIENT. RESULTS: BOTH YOGA GROUPS WERE BETTER THAN DRUGS-ONLY GROUP WITH RESPECT TO REDUCTION IN HDRS SCORES. SERUM BDNF ROSE IN THE TOTAL SAMPLE IN THE 3-MONTH PERIOD. THIS WAS NOT, HOWEVER, DIFFERENT ACROSS TREATMENT GROUPS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN FALL IN HDRS AND RISE IN SERUM BDNF LEVELS IN YOGA-ONLY GROUP (R=0.702; P=0.001), BUT NOT IN THOSE RECEIVING YOGA AND ANTIDEPRESSANTS OR ANTIDEPRESSANTS-ALONE. CONCLUSIONS: NEUROPLASTIC MECHANISMS MAY BE RELATED TO THE THERAPEUTIC MECHANISMS OF YOGA IN DEPRESSION. 2013 4 1542 34 KRIYA YOGA IN PATIENTS WITH DEPRESSIVE DISORDERS: A PILOT STUDY. BACKGROUND AND OBJECTIVES DESPITE THE EASY ACCEPTABILITY AND HOLISTIC NATURE OF KRIYA YOGA, THERE ARE NO STUDIES EVALUATING THE ROLE OF KRIYA YOGA INTERVENTION ON DEPRESSION. THE OBJECTIVE OF THE CURRENT STUDY WAS TO ASSESS THE FEASIBILITY AND EFFECT OF ADJUNCTIVE KRIYA YOGA ON DEPRESSION. METHODS PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO OPTED FOR KRIYA YOGA WERE RECRUITED INTO THE INTERVENTION GROUP (ADJUNCTIVE KRIYA YOGA) AND THOSE ON PSYCHOTROPIC MEDICATION ALONE WERE ENROLLED INTO THE CONTROL GROUP. THE HAMILTON DEPRESSION RATING SCALE (HDRS) MEASUREMENTS WERE RECORDED AT BASELINE, END OF 2, 4, AND 8 WEEKS. RESULTS HDRS SCORES OF THE INTERVENTION GROUP ( N = 29) WERE FOUND TO BE SIGNIFICANTLY LESSER THAN THAT OF THE CONTROL GROUP ( N = 52) BY THE END OF 2, 4, AND 8 WEEKS. THE REMISSION RATE WAS ALSO SIGNIFICANTLY GREATER IN THE INTERVENTION GROUP. CONCLUSION KRIYA YOGA INTERVENTION WAS FOUND TO BE FEASIBLE, AS WELL AS IMPROVED THE SEVERITY OF DEPRESSION. 2021 5 555 53 CORTISOL AND ANTIDEPRESSANT EFFECTS OF YOGA. CONTEXT: HYPERCORTISOLEMIA IS WELL-KNOWN IN DEPRESSION AND YOGA HAS BEEN DEMONSTRATED EARLIER TO REDUCE THE PARAMETERS OF STRESS, INCLUDING CORTISOL LEVELS. AIM: WE AIMED TO FIND THE ROLE OF YOGA AS AN ANTIDEPRESSANT AS WELL AS ITS ACTION ON LOWERING THE SERUM CORTISOL LEVELS. SETTINGS AND DESIGN: AN OPEN-LABELED STUDY CONSISTING OF THREE GROUPS (YOGA ALONE, YOGA ALONG WITH ANTIDEPRESSANT MEDICATION AND ANTIDEPRESSANT MEDICATION ALONE) WAS CONDUCTED AT A TERTIARY CARE PSYCHIATRY HOSPITAL. METHODOLOGY: OUT-PATIENT DEPRESSIVES WHO WERE NOT SUICIDAL WERE OFFERED YOGA AS A POSSIBLE ANTIDEPRESSANT THERAPY. A VALIDATED YOGA MODULE WAS USED AS THERAPY TAUGHT OVER A MONTH AND TO BE PRACTICED AT HOME DAILY. PATIENTS WERE FREE TO CHOOSE THE DRUGS IF THEIR PSYCHIATRIST ADVISED. PATIENTS (N=54) WERE RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) WITH SERUM CORTISOL MEASUREMENTS AT BASELINE AND AFTER 3 MONTHS. IN 54 PATIENTS, ASSESSMENTS AND BLOOD TEST RESULTS WERE BOTH AVAILABLE. 19 EACH RECEIVED YOGA ALONE OR WITH DRUGS AND 16 RECEIVED DRUGS ONLY. HEALTHY COMPARISON SUBJECTS (N=18) TOO UNDERWENT MORNING CORTISOL MEASUREMENTS ONCE. RESULTS: SERUM CORTISOL WAS HIGHER IN DEPRESSIVES COMPARED WITH CONTROLS. IN THE TOTAL SAMPLE, THE CORTISOL LEVEL DROPPED SIGNIFICANTLY AT THE END OF TREATMENT. MORE PATIENTS IN THE YOGA GROUPS HAD A DROP IN CORTISOL LEVELS AS COMPARED TO DRUG-ONLY GROUP. IN THE YOGA-ONLY GROUP, THE CORTISOL DROP CORRELATED WITH THE DROP IN HDRS SCORE (ANTIDEPRESSANT EFFECT). CONCLUSION: THE FINDINGS SUPPORT THAT YOGA MAY ACT AT THE LEVEL OF THE HYPOTHALAMUS BY ITS 'ANTI-STRESS' EFFECTS (REDUCING THE CORTISOL), TO BRING ABOUT RELIEF IN DEPRESSION. 2013 6 835 34 EFFECT OF YOGA ON PAIN, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND SEROTONIN IN PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN. BACKGROUND. SEROTONIN AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) ARE KNOWN TO BE MODULATORS OF NOCICEPTION. HOWEVER, PAIN-RELATED CONNECTION BETWEEN YOGA AND THOSE NEUROMODULATORS HAS NOT BEEN INVESTIGATED. THEREFORE, WE AIMED TO EVALUATE THE EFFECT OF YOGA ON PAIN, BDNF, AND SEROTONIN. METHODS. PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN PRACTICED YOGA THREE TIMES A WEEK FOR 12 WEEKS. AT BASELINE AND AFTER 12 WEEKS, BACK PAIN INTENSITY WAS MEASURED USING VISUAL ANALOGUE SCALE (VAS), AND SERUM BDNF AND SEROTONIN LEVELS WERE EVALUATED. ADDITIONALLY, BACK FLEXIBILITY AND LEVEL OF DEPRESSION WERE ASSESSED. RESULTS. AFTER 12-WEEK YOGA, VAS DECREASED IN THE YOGA GROUP (P < 0.001), WHEREAS IT INCREASED (P < 0.05) IN THE CONTROL GROUP. BACK FLEXIBILITY WAS IMPROVED IN THE YOGA GROUP (P < 0.01). SERUM BDNF INCREASED IN THE YOGA GROUP (P < 0.01), WHEREAS IT TENDED TO DECREASE IN THE CONTROL GROUP (P = 0.05). SERUM SEROTONIN MAINTAINED IN THE YOGA GROUP, WHILE IT REDUCED (P < 0.01) IN THE CONTROL GROUP. THE DEPRESSION LEVEL MAINTAINED IN THE YOGA GROUP, WHEREAS IT TENDED TO INCREASE IN THE CONTROL GROUP (P = 0.07). CONCLUSIONS. WE PROPOSE THAT BDNF MAY BE ONE OF THE KEY FACTORS MEDIATING BENEFICIAL EFFECTS OF YOGA ON CHRONIC LOW BACK PAIN. 2014 7 2119 32 THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MALE PATIENTS WITH INSOMNIA. BACKGROUND: AN ESTIMATED 30-50% OF THE GENERAL POPULATION IS AFFECTED BY INSOMNIA AND 10% HAVE CHRONIC INSOMNIA. YOGA THERAPY IS BENEFICIAL IN SUCH DISORDERS AND IT HAS FEWER SIDE EFFECTS. AIM: THE AIM OF THIS STUDY WAS TO FIND OUT THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MEN WITH INSOMNIA. METHODS: FORTY MALES WITH INSOMNIA WERE DIVIDED RANDOMLY INTO 2 GROUPS (THE EXPERIMENTAL AND THE CONTROL GROUPS). THE EXPERIMENTAL GROUP RECEIVED EIGHT WEEKS OF YOGA THERAPY, WHILE THE CONTROL GROUP DID NOT RECEIVE ANY THERAPY. THE PRE AND POST TREATMENT STRESS AND THE SELF CONFIDENCE SCORES WERE TAKEN. RESULTS: THERE WAS A SIGNIFICANT IMPROVEMENT IN THE STRESS SCORES AND THE SELF CONFIDENCE SCORES IN THE EXPERIMENTAL GROUP. THERE WERE NEITHER ANY SIDE EFFECTS NOR ANY DROP OUTS. CONCLUSION: WE CONCLUDE THAT YOGA IS AN EFFECTIVE TREATMENT OPTION FOR THE PATIENTS WITH INSOMNIA. THERE ARE NO MAJOR SIDE EFFECTS. 2013 8 1076 33 EFFECTS OF YOGA ON PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING IN MULTIPLE SCLEROSIS PATIENTS: A RANDOMIZED TRIAL. INTRODUCTION: MULTIPLE SCLEROSIS (MS) AS A CHRONIC DISEASE COULD AFFECT PATIENTS' VARIOUS DOMAINS OF LIFE. AIM: THIS STUDY WAS CONDUCTED TO STUDY THE EFFECT OF YOGA ON THE PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING OF PATIENTS WITH MS IN SOUTHWEST, IRAN. MATERIALS AND METHODS: IN THIS CLINICAL TRIAL STUDY, 60 MS PATIENTS WERE ENROLLED ACCORDING TO INCLUSION CRITERIA AND RANDOMLY ASSIGNED TO TWO GROUPS OF 30 EACH. PRIOR TO AND AFTER INTERVENTION, THE PATIENTS' VITAL SIGNS WERE MEASURED. FOR CASE GROUP YOGA EXERCISES WERE PERFORMED THREE SESSIONS A WEEK FOR 12 WEEKS WHILE CONTROL GROUP PERFORMED NO EXERCISE. THE DATA WERE GATHERED BY QUESTIONNAIRE AND ANALYSED BY DESCRIPTIVE AND ANALYTICAL STATISTICS IN SPSS. RESULTS: PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN FATIGUE SEVERITY AND PAIN BETWEEN THE TWO GROUPS BUT THE MEAN FATIGUE SEVERITY AND PAIN IN CASE GROUP DECREASED COMPARED TO THE CONTROL GROUP AFTER THE INTERVENTION. PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN MEAN PHYSIOLOGICAL INDICES BETWEEN THE TWO GROUPS BUT THE MEAN PHYSIOLOGICAL INDICES IN CASE GROUP DECREASED SIGNIFICANTLY AFTER THE INTERVENTION (P<0.05). CONCLUSION: YOGA IS LIKELY TO INCREASE SELF-EFFICACY OF MS PATIENTS THROUGH ENHANCING PHYSICAL ACTIVITY, INCREASING THE STRENGTH OF LOWER LIMBS AND BALANCE, AND DECREASING FATIGUE AND PAIN, AND FINALLY TO PROMOTE SOCIAL FUNCTIONING AND TO RELIEVE STRESS AND ANXIETY IN THESE PATIENTS. 2016 9 1450 36 INFLUENCE OF INTENSITY AND DURATION OF YOGA ON ANXIETY AND DEPRESSION SCORES ASSOCIATED WITH CHRONIC ILLNESS. BACKGROUND: CHRONIC ILLNESS IS COMMONLY ASSOCIATED WITH ANXIETY AND DEPRESSION. BOTH ANXIETY AND DEPRESSION RESPOND TO YOGA. HOWEVER, THERE IS NO REPORT ON THE ASSOCIATION BETWEEN THE INTENSITY AND DURATION OF YOGA PRACTICE WITH THE BENEFITS SEEN. AIM: THE PRESENT STUDY WAS INTENDED TO DETERMINE WHETHER THE DAILY DURATION OF YOGA PRACTICE AND THE DURATION OF EXPERIENCE IN MONTHS WOULD PREDICT ANXIETY AND DEPRESSION, ASSOCIATED WITH CHRONIC ILLNESS. SUBJECTS AND METHODS: SEVEN HUNDRED AND SIXTY-THREE VOLUNTEERS WITH AGES BETWEEN 14 AND 86 YEARS (GROUP MEAN AGE STANDARD DEVIATION, 50.2 [14.2]) WHO ATTENDED A 7 DAY RESIDENTIAL YOGA CAMP IN THE NORTH OF INDIA WERE INCLUDED IN THIS CROSS-SECTIONAL STUDY. ALL PARTICIPANTS HAD CHRONIC ILLNESSES, WHICH WERE UNDER CONTROL WITH TREATMENT, AND WHICH WERE CATEGORIZED AND ARE DETAILED. PARTICIPANTS WERE ASSESSED FOR STATE ANXIETY SCORES USING STATE-TRAIT ANXIETY INVENTORY AND FOR ANXIETY WITH HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS-A), AND DEPRESSION WAS ASSESSED USING HADS-D SCORES OF THE HADS. LINEAR MULTIPLE REGRESSION ANALYSES WERE PERFORMED USING PASW SPSS VERSION 18.0 (ARMONK, NEW YORK, U.S.) TO DETERMINE HOW THE DAILY AND MONTHLY DURATION OF YOGA PRACTICE COULD INFLUENCE STATE ANXIETY, HOSPITAL ANXIETY AND DEPRESSION OF THE PARTICIPANTS. RESULTS: YOGA PRACTICE IN MONTHS AND THE TIME SPENT PRACTICING YOGA EACH DAY SIGNIFICANTLY PREDICT THE LEVEL OF STATE ANXIETY (P < 0.001, P = 0.03) AND HAD-A (P < 0.01, P < 0.01). THE DURATION OF YOGA PRACTICE IN MONTHS ALONE WAS A SIGNIFICANT PREDICTOR OF THE HAD-D (P < 0.01). CONCLUSIONS: THE RESULTS SUGGEST THAT THE DURATION OF YOGA PRACTICE IN MONTHS AND DAILY PRACTICE IN MINUTES PREDICT ANXIETY ASSOCIATED WITH CHRONIC ILLNESS. IN CONTRAST THE DURATION OF YOGA PRACTICE IN MONTHS ALONE, PREDICTED DEPRESSION SCORES. 2015 10 1041 42 EFFECTS OF YOGA INTERVENTION ON SLEEP AND QUALITY-OF-LIFE IN ELDERLY: A RANDOMIZED CONTROLLED TRIAL. CONTEXT: YOGA AS A LIFE-STYLE PRACTICE HAS DEMONSTRATED BENEFICIAL EFFECTS. THE ROLE OF YOGA IN THE ELDERLY FOR SUCH BENEFITS MERITS INVESTIGATION. AIMS: THE AIM OF THIS STUDY IS TO EXAMINE THE EFFECTS OF YOGA INTERVENTION ON QUALITY-OF-LIFE (QOL) AND SLEEP QUALITY IN THE ELDERLY LIVING IN OLD AGE HOMES. SETTINGS AND DESIGN: SINGLE BLIND CONTROLLED STUDY WITH BLOCK RANDOMIZATION OF ELDERLY HOMES. MATERIALS AND METHODS: A TOTAL OF 120 SUBJECTS FROM NINE ELDERLY HOMES WERE RANDOMIZED IN TO YOGA GROUP (N=62) AND WAITLIST GROUP (N=58). SUBJECTS IN THE YOGA GROUP WERE GIVEN YOGA INTERVENTION DAILY FOR 1 MONTH AND WEEKLY UNTIL 3 MONTHS AND WERE ENCOURAGED TO PRACTICE YOGA WITHOUT SUPERVISION UNTIL FOR 6 MONTHS. SUBJECTS IN WAITLIST GROUP RECEIVED NO INTERVENTION DURING THIS PERIOD. SUBJECTS WERE EVALUATED WITH WORLD HEALTH ORGANIZATION QUALITY OF LIFE (WHOQOL)-BREF FOR MEASURING QOL AND PITTSBURGH SLEEP QUALITY INDEX FOR SLEEP QUALITY IN THE BASELINE AND AFTER 6 MONTHS. STATISTICAL ANALYSIS: INDEPENDENT T-TEST AND REPEATED MEASURES ANALYSIS OF COVARIANCE RESPECTIVELY WAS USED TO MEASURE THE DIFFERENCE IN OUTCOME MEASURES BETWEEN THE TWO GROUPS AT BASELINE AND AFTER THE STUDY PERIOD. RESULTS: SUBJECTS IN THE YOGA GROUP HAD SIGNIFICANTLY HIGHER NUMBER OF YEARS OF FORMAL EDUCATION. SUBJECTS IN THE YOGA GROUP HAD SIGNIFICANT IMPROVEMENT IN ALL THE DOMAINS OF QOL AND TOTAL SLEEP QUALITY AFTER CONTROLLING FOR THE EFFECT OF BASELINE DIFFERENCE IN EDUCATION BETWEEN THE TWO GROUPS. CONCLUSION: YOGA INTERVENTION APPEARS TO IMPROVE THE QOL AND SLEEP QUALITY OF ELDERLY LIVING IN OLD AGE HOMES. THERE IS A NEED FOR FURTHER STUDIES OVERCOMING THE LIMITATIONS IN THIS STUDY TO CONFIRM THE BENEFITS OF YOGA FOR ELDERLY IN QOL AND SLEEP QUALITY. 2013 11 2293 37 THERAPEUTIC EFFICACY OF ADD-ON YOGASANA INTERVENTION IN STABILIZED OUTPATIENT SCHIZOPHRENIA: RANDOMIZED CONTROLLED COMPARISON WITH EXERCISE AND WAITLIST. BACKGROUND: SCHIZOPHRENIA IS A HIGHLY DISABLING ILLNESS. PREVIOUS STUDIES HAVE SHOWN YOGA TO BE A FEASIBLE ADD-ON THERAPY IN SCHIZOPHRENIA. AIMS: THE CURRENT STUDY AIMED TO TEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT IN OUTPATIENTS WITH SCHIZOPHRENIA. SETTINGS AND DESIGN: THE STUDY DONE AT A TERTIARY PSYCHIATRY CENTER USED A SINGLE BLIND RANDOMIZED CONTROLLED DESIGN WITH ACTIVE CONTROL AND WAITLIST GROUPS. MATERIALS AND METHODS: CONSENTING PATIENTS WITH SCHIZOPHRENIA WERE RANDOMIZED INTO YOGA, EXERCISE, OR WAITLIST GROUP. THEY CONTINUED TO RECEIVE PHARMACOLOGICAL THERAPY THAT WAS UNCHANGED DURING THE STUDY. PATIENTS IN THE YOGA OR EXERCISE GROUP WERE OFFERED SUPERVISED DAILY PROCEDURES FOR ONE MONTH. ALL PATIENTS WERE ASSESSED BY A BLIND RATER AT THE START OF THE INTERVENTION AND AT THE END OF 4 MONTHS. RESULTS: KENDALL TAU, A NONPARAMETRIC STATISTICAL TEST, SHOWED THAT SIGNIFICANTLY MORE PATIENTS IN THE YOGA GROUP IMPROVED IN POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) NEGATIVE AND TOTAL PANSS SCORES AS WELL AS SOCIAL FUNCTIONING SCORES COMPARED WITH THE EXERCISE AND WAITLIST GROUP. ODDS RATIO ANALYSIS SHOWED THAT THE LIKELIHOOD OF IMPROVEMENT IN YOGA GROUP IN TERMS OF NEGATIVE SYMPTOMS WAS ABOUT FIVE TIMES GREATER THAN EITHER THE EXERCISE OR WAITLIST GROUPS. CONCLUSION: IN SCHIZOPHRENIA PATIENTS WITH SEVERAL YEARS OF ILLNESS AND ON STABILIZED PHARMACOLOGICAL THERAPY, ONE-MONTH TRAINING FOLLOWED BY THREE MONTHS OF HOME PRACTICES OF YOGA AS AN ADD-ON TREATMENT OFFERED SIGNIFICANT ADVANTAGE OVER EXERCISE OR TREATMENT AS USUAL. YOGA HOLDS PROMISE AS A COMPLEMENTARY INTERVENTION IN THE MANAGEMENT OF SCHIZOPHRENIA. 2012 12 2702 40 YOGA INTERVENTION ON BLOOD NO IN FEMALE MIGRAINEURS. BACKGROUND: THE CURRENT SURVEY INVESTIGATES THE EFFECT OF 12 WEEKS YOGA TRAINING ON HEADACHE FREQUENCY, SEVERITY, DURATION AND BLOOD NITRIC OXIDE LEVELS AS WELL AS HEADACHE IMPACTS ON FEMALE MIGRAINEURS' LIVES. MATERIALS AND METHODS: THIRTY-TWO FEMALE PATIENTS WITH MIGRAINE TOOK PART AND WERE RANDOMLY DIVIDED INTO TWO GROUPS. THE CONTROL GROUP (N = 14) RECEIVED MEDICATION AND THE YOGA GROUP (N = 18) PARTICIPATED IN 12 WEEKS YOGA TRAINING IN ADDITION TO RECEIVING THE SAME MEDICATION AS THAT OF THE CONTROL GROUP. FREQUENCY AND DURATION OF HEADACHE WERE ASSESSED BY A QUESTIONNAIRE. VISUAL ANALOGUE SCALE WAS USED TO MEASURE THE SEVERITY OF HEADACHE, AND THE METABOLITE OF NO ALSO WAS MEASURED BY GRIESS REACTION. HEADACHE IMPACT TEST (HIT-6) WAS ALSO USED TO ASSESS THE IMPACT OF HEADACHE ON PATIENTS' LIVES. DATA WERE ANALYZED BY T-TEST MEAN VARIANCE. RESULTS: AFTER 3 MONTHS INTERVENTION, IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN THE IMPACT OF HEADACHE ON PATIENTS' LIVES, HEADACHE FREQUENCY, AND SEVERITY AND A NON-SIGNIFICANT REDUCTION IN HEADACHE DURATION IN THE YOGA GROUP. THERE WAS NO SIGNIFICANT DIFFERENCE IN THE PLASMA LEVELS OF NO BETWEEN YOGA AND CONTROL GROUPS BEFORE AND AFTER THE STUDY. CONCLUSION: BASED ON THE RESULTS, YOGA COULD BE RECOMMENDED AS A COMPLEMENTARY METHOD TO MIGRAINE PATIENTS. 2015 13 1402 40 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179/ 0.05). STATISTICALLY SIGNIFICANT DIFFERENCE WAS OBSERVED IN THE MEAN LEVEL OF PERCEIVED FATIGUE IN TRIPLICATE MEASUREMENTS (P = 0.013) AMONG PATIENTS WHO COMPLETED INDIVIDUAL EXERCISE. HOWEVER, THIS DIFFERENCE WAS NOT SIGNIFICANT IN THE GROUP EXERCISE. CONCLUSION: PERFORMING MILD STRETCHING EXERCISES AND BASIC YOGA ARE RECOMMENDED AS A COST-EFFECTIVE METHOD WHICH IS EASY TO PERFORM AMONG PATIENTS WITH MILD TO MODERATE DISABILITIES. 2015 19 1129 37 EFFICACY OF YOGA AS AN ADD-ON TREATMENT FOR IN-PATIENTS WITH FUNCTIONAL PSYCHOTIC DISORDER. CONTEXT: THE EFFICACY OF YOGA AS AN INTERVENTION FOR IN-PATIENTS WITH PSYCHOSIS IS AS YET UNKNOWN; ALTHOUGH, PREVIOUS STUDIES HAVE SHOWN EFFICACY IN STABILIZED OUT-PATIENTS WITH SCHIZOPHRENIA. AIM: THIS STUDY AIMED TO COMPARE THE EFFECT OF ADD-ON YOGA THERAPY OR PHYSICAL EXERCISE ALONG WITH STANDARD PHARMACOTHERAPY IN THE TREATMENT OF IN-PATIENTS WITH PSYCHOSIS. SETTINGS AND DESIGN: THIS STUDY WAS PERFORMED IN AN IN-PATIENT SETTING USING A RANDOMIZED CONTROLLED SINGLE BLIND DESIGN. MATERIALS AND METHODS: A TOTAL OF 88 CONSENTING IN-PATIENTS WITH PSYCHOSIS WERE RANDOMIZED INTO YOGA THERAPY GROUP (N=44) AND PHYSICAL EXERCISE GROUP (N=44). SIXTY PATIENTS COMPLETED THE STUDY PERIOD OF 1(1/2) MONTHS. PATIENTS WHO COMPLETED IN THE YOGA GROUP (N=35) AND IN THE EXERCISE GROUP (N=25) WERE SIMILAR ON THE DEMOGRAPHIC PROFILE, ILLNESS PARAMETERS AND PSYCHOPATHOLOGY SCORES AT BASELINE. RESULTS: THE TWO TREATMENT GROUPS WERE NOT DIFFERENT ON THE CLINICAL SYNDROME SCORES AT THE END OF 2 WEEKS. AT THE END OF 6 WEEKS, PATIENTS IN THE YOGA GROUP HOWEVER HAD LOWER MEAN SCORES ON CLINICAL GLOBAL IMPRESSION SEVERITY (CGIS), POSITIVE AND NEGATIVE SYNDROME SCALE (TOTAL AND GENERAL PSYCHOPATHOLOGY SUBSCALE) AND HAMILTON DEPRESSION RATING SCALE (HDRS) (P<0.05). REPEATED MEASURE ANALYSIS OF VARIANCE DETECTED AN ADVANTAGE FOR YOGA OVER EXERCISE IN REDUCING THE CLINICAL CGIS AND HDRS SCORES. CONCLUSION: ADDING YOGA INTERVENTION TO STANDARD PHARMACOLOGICAL TREATMENT IS FEASIBLE AND MAY BE BENEFICIAL EVEN IN THE EARLY AND ACUTE STAGE OF PSYCHOSIS. 2013 20 723 30 EFFECT OF LAUGHTER YOGA ON MENTAL SYMPTOMS AND SALIVARY CORTISOL LEVELS IN FIRST-YEAR NURSING STUDENTS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: UNIVERSITY STUDENTS ARE FACED WITH SEVERAL STRESS FACTORS AFFECTING THEIR MENTAL HEALTH. THEREFORE, THE FIRST YEAR AT UNIVERSITY IS A PERIOD THAT CALLS FOR CAREFUL ATTENTION AND RESEARCH. AIM: THE AIM OF THIS STUDY IS TO EVALUATE THE EFFECT OF LAUGHTER YOGA ON MENTAL SYMPTOMS AND CORTISOL LEVELS IN NURSING STUDENTS. METHODS: THIS STUDY IS A RANDOMIZED CONTROLLED STUDY EMPLOYING A PRE-/POST-TEST DESIGN WITH A CONTROL GROUP. A TOTAL OF 75 HEALTHY UNIVERSITY STUDENTS WERE ASSIGNED TO THE INTERVENTION GROUP AND CONTROL GROUP. THE BRIEF SYMPTOM INVENTORY WAS APPLIED TO BOTH GROUPS BEFORE SESSION 1 AND AFTER SESSION 8. SALIVA SAMPLES WERE TAKEN FROM THE STUDENTS TO MEASURE THEIR CORTISOL LEVELS BEFORE AND AFTER EACH SESSION. RESULTS: EVALUATION OF THE MEAN SCORES OBTAINED FROM THE BRIEF SYMPTOM INVENTORY BEFORE AND AFTER THE INTERVENTION SHOWED A SIGNIFICANT DECREASE IN THE SCORES BETWEEN GROUPS (P < 0.05). IN THREE OUT OF THE EIGHT SESSIONS, THERE WAS A SIGNIFICANT DECREASE IN THE INTERVENTION GROUP COMPARED WITH THE CONTROL GROUP REGARDING THE MEAN VALUES OF PRE-TEST AND POST-TEST SALIVARY CORTISOL LEVELS (P < 0.05). CONCLUSION: LAUGHTER YOGA CAN PROVIDE AN EFFECTIVE MEANS TO HELP FIRST-YEAR NURSING STUDENTS COPE WITH STRESS AND REDUCE MENTAL SYMPTOMS. 2021